Literature DB >> 20373065

Significant pregabalin toxicity managed with supportive care alone.

David M Wood1, David J Berry, Guy Glover, Jane Eastwood, Paul I Dargan.   

Abstract

There are two previously reported cases describing the management of pregabalin self-poisoning and one further case of management of therapeutic pregabalin accumulation. The peak reported pregabalin concentrations in these cases ranged from 13 mg/L to approximately 60 mg/L. Previous case reports have suggested that both supportive care and enhanced elimination are appropriate managements for pregabalin toxicity. A 54-year-old male presented following ingestion of 8.4 g of pregabalin. Initially, he had no clinical features of toxicity, although he developed significant neurological depression and coma approximately 3 h post-ingestion. He was managed with supportive care (including endotracheal intubation and mechanical ventilation) until his level of consciousness improved. Subsequent toxicological screening confirmed isolated pregabalin ingestion, with a serum pregabalin concentration of 66.5 mg/L at the time he clinically deteriorated. The pharmacokinetic properties of pregabalin indicate the potential value of extra-corporeal elimination methods such as haemodialysis. Clinical toxicologists should be aware that whilst there is a pharmacokinetic basis for the use of extra-corporeal methods in those with severe toxicity arising from excessive plasma pregabalin concentrations, there are case reports, including this one, where patients have been managed with supportive measures only.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20373065      PMCID: PMC3550463          DOI: 10.1007/s13181-010-0052-3

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN: 1556-9039


  7 in total

Review 1.  Abuse and Misuse of Pregabalin and Gabapentin.

Authors:  Kirk E Evoy; Megan D Morrison; Stephen R Saklad
Journal:  Drugs       Date:  2017-03       Impact factor: 9.546

2.  Pregabalin poisoning and rising recreational use: a retrospective observational series.

Authors:  Katherine Z Isoardi; Gregory Polkinghorne; Keith Harris; Geoffrey K Isbister
Journal:  Br J Clin Pharmacol       Date:  2020-06-05       Impact factor: 4.335

3.  Intentional Drug Overdose Involving Pregabalin and Gabapentin: Findings from the National Self-Harm Registry Ireland, 2007-2015.

Authors:  Caroline Daly; Eve Griffin; Darren M Ashcroft; Roger T Webb; Ivan J Perry; Ella Arensman
Journal:  Clin Drug Investig       Date:  2018-04       Impact factor: 2.859

4.  Pregabalin for the treatment of generalized anxiety disorder: an update.

Authors:  David S Baldwin; Khalil Ajel; Vasilios G Masdrakis; Magda Nowak; Rizwan Rafiq
Journal:  Neuropsychiatr Dis Treat       Date:  2013-06-24       Impact factor: 2.570

5.  Pregabalin poisoning: Evaluation of dose-toxicity relationship.

Authors:  Saskia J Rietjens; Maaike A Sikma; Claudine C Hunault; Dylan W de Lange; Laura Hondebrink
Journal:  Br J Clin Pharmacol       Date:  2021-10-08       Impact factor: 3.716

6.  Coma With Absent Brainstem Reflexes and a Burst Suppression on EEG Secondary to Baclofen Toxicity.

Authors:  Sahar Farhat; Tarek El Halabi; Achraf Makki; Samir F Atweh; Wassim Nasreddine; Ahmad Beydoun
Journal:  Front Neurol       Date:  2020-05-13       Impact factor: 4.003

7.  Pregabalin-associated myoclonic encephalopathy without evidence of drug accumulation in a patient with acute renal failure.

Authors:  F Courtois; D Borrey; V Haufroid; P Hantson
Journal:  Indian J Nephrol       Date:  2014-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.